文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一项针对2型糖尿病患者的数字教育干预措施的疗效:多中心、随机、前瞻性、6个月随访研究。

Efficacy of a Digital Educational Intervention for Patients With Type 2 Diabetes Mellitus: Multicenter, Randomized, Prospective, 6-Month Follow-Up Study.

作者信息

Caballero Mateos Irene, Morales Portillo Cristóbal, Lainez López María, Vilches-Arenas Ángel

机构信息

Endocrinology and Nutrition Department, Vithas Hospital, Sevilla, Spain.

Endocrinology and Nutrition Department, Juan Ramón Jiménez University Hospital, Huelva, Spain.

出版信息

J Med Internet Res. 2025 Apr 10;27:e60758. doi: 10.2196/60758.


DOI:10.2196/60758
PMID:40209213
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12022518/
Abstract

BACKGROUND: Adherence to therapies and metabolic control among patients with type 2 diabetes mellitus (T2DM) remain challenging. The use of new technologies, such as telemedicine, digitalized systems, and social networks, could improve self-management and disease control. OBJECTIVE: We evaluated the efficacy of a digital educational intervention for patients with T2DM, expressed as changes in glycated hemoglobin (HbA) and body composition and evaluation of the response using validated questionnaires of satisfaction with health care professionals (Instrument for Evaluation of the Experience of Chronic Patients), Diabetes Knowledge Scale (ECODI), and adherence to treatment over 6 months of follow-up (Morisky, Green, Levine Medication Assessment Questionnaire). METHODS: This multicenter, randomized, prospective study included adults with T2DM with poor metabolic control who started treatment with glucagon-like peptide-1 receptor agonists. Patients were randomized to digital intervention or usual care. The intervention group received education through social networks and digital tools in a structured program of healthy lifestyle changes. This was provided by a "Digital Coach" for weekly and on-demand advice and individualized support. Baseline and follow-up demographic, clinical parameter, adherence, and quality of life data were collected. RESULTS: We included 85 patients (control: n=41; intervention: n=44). Both groups were matched regarding demographics, physical examination, insulin, and biochemical parameters. We observed a reduction in body weight (intervention: -8.7, SD 6.1 kg vs control: -4.9, SD 5.0 kg; t=-3.13; P=.002), BMI (intervention: -3.0, SD 2.1 kg/m vs control: -1.8, SD 1.8 kg/m; t=-2.82; P=.006), and fast mass in both groups but greater in the intervention group. There were greater reductions in fasting plasma glucose (intervention: 122.6, SD 81.5 mg/dL vs control: 70.5, SD 72.9 mg/dL; t=3.10; P=.004) and HbA (intervention: 3.7%, SD 1.9% vs control: 2.6%, SD 2.1%; t=2.54; P=.006) in the intervention group. Although there was no significant change in the Spanish version of the Diabetes Quality of Life Questionnaire (EsDQOL) satisfaction score in the control group after 6 months of follow-up (0.7, SD 19.8), there was a marked reduction in EsDQOL satisfaction score in the intervention group (-13.7, SD 23.1; t=-3.08; P=.02). According to the ECODI scale, knowledge about diabetes increased more in the intervention group (intervention: 0.3, SD 1.8 vs control: 1.5, SD 1.5; t=-3.33; P=.001). Although the medication adherence score worsened in the control group after 6 months, it significantly improved with the intervention (control: -8% vs intervention: 13.8%; χ=0.35; P=.01). Patients' health care experiences improved with the intervention but not with the control. CONCLUSIONS: The digital educational intervention was effective at improving glycemic control, body composition, adherence, and patient satisfaction compared with usual care in patients with T2DM. The implementation of digital tools and social media could highly improve the multidisciplinary approach to the management of this population. TRIAL REGISTRATION: ClinicalTrials.gov NCT06850129; https://clinicaltrials.gov/study/NCT06850129.

摘要

背景:2型糖尿病(T2DM)患者的治疗依从性和代谢控制仍然具有挑战性。使用新技术,如远程医疗、数字化系统和社交网络,可能会改善自我管理和疾病控制。 目的:我们评估了针对T2DM患者的数字教育干预的效果,以糖化血红蛋白(HbA)和身体成分的变化来表示,并使用经过验证的对医护人员满意度问卷(慢性病患者体验评估工具)、糖尿病知识量表(ECODI)以及随访6个月期间的治疗依从性问卷(Morisky-Green-Levine药物评估问卷)来评估反应情况。 方法:这项多中心、随机、前瞻性研究纳入了代谢控制不佳且开始使用胰高血糖素样肽-1受体激动剂治疗的成年T2DM患者。患者被随机分为数字干预组或常规治疗组。干预组通过社交网络和数字工具接受关于健康生活方式改变的结构化教育项目。由一名“数字教练”提供每周一次的按需建议和个性化支持。收集基线和随访时的人口统计学、临床参数、依从性和生活质量数据。 结果:我们纳入了85名患者(对照组:n = 41;干预组:n = 44)。两组在人口统计学、体格检查、胰岛素和生化参数方面相匹配。我们观察到两组患者的体重(干预组:-8.7,标准差6.1 kg,对照组:-4.9,标准差5.0 kg;t = -3.13;P = 0.002)、体重指数(干预组:-3.0,标准差2.1 kg/m²,对照组:-1.8,标准差1.8 kg/m²;t = -2.82;P = 0.006)和去脂体重均有所下降,但干预组下降幅度更大。干预组的空腹血糖(干预组:122.6,标准差81.5 mg/dL,对照组:70.5,标准差72.9 mg/dL;t = 3.10;P = 0.004)和HbA(干预组:3.7%,标准差1.9%,对照组:2.6%,标准差2.1%;t = 2.54;P = 0.006)下降幅度更大。尽管随访6个月后对照组的西班牙文版糖尿病生活质量问卷(EsDQOL)满意度得分无显著变化(0.7,标准差19.8),但干预组的EsDQOL满意度得分显著降低(-13.7,标准差23.1;t = -3.08;P = 0.02)。根据ECODI量表,干预组患者对糖尿病的知识增加更多(干预组:0.3,标准差1.8,对照组:1.5,标准差1.5;t = -3.33;P = 0.001)。尽管对照组在6个月后的药物依从性得分变差,但干预组使其显著改善(对照组:-8%,干预组:13.8%;χ² = 0.35;P = 0.01)。干预改善了患者的医疗体验,而对照组则未改善。 结论:与T2DM患者的常规治疗相比,数字教育干预在改善血糖控制、身体成分、依从性和患者满意度方面是有效的。数字工具和社交媒体的应用可以极大地改善对这一人群的多学科管理方法。 试验注册:ClinicalTrials.gov NCT06850129;https://clinicaltrials.gov/study/NCT06850129

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/12022518/6f2694d173a9/jmir_v27i1e60758_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/12022518/05060e833411/jmir_v27i1e60758_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/12022518/6f2694d173a9/jmir_v27i1e60758_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/12022518/05060e833411/jmir_v27i1e60758_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/12022518/6f2694d173a9/jmir_v27i1e60758_fig2.jpg

相似文献

[1]
Efficacy of a Digital Educational Intervention for Patients With Type 2 Diabetes Mellitus: Multicenter, Randomized, Prospective, 6-Month Follow-Up Study.

J Med Internet Res. 2025-4-10

[2]
Health Coaching Reduces HbA1c in Type 2 Diabetic Patients From a Lower-Socioeconomic Status Community: A Randomized Controlled Trial.

J Med Internet Res. 2015-10-5

[3]
Clinical Impact of Personalized Physician's Education and Remote Feedback Via a Digital Platform on Glycemic Control: Pilot Randomized Controlled Trial.

JMIR Mhealth Uhealth. 2025-5-1

[4]
Efficacy of a Mobile Health-Based Behavioral Treatment for Lifestyle Modification in Type 2 Diabetes Self-Management: Greenhabit Randomized Controlled Trial.

J Med Internet Res. 2025-1-22

[5]
Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial.

Circ Cardiovasc Qual Outcomes. 2019-9

[6]
Mobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical Trial.

JAMA Netw Open. 2023-9-5

[7]
Digital Storytelling Intervention for Hemoglobin A1c Control Among Hispanic Adults With Type 2 Diabetes: A Randomized Clinical Trial.

JAMA Netw Open. 2024-8-1

[8]
Mobile Delivery of the Diabetes Prevention Program in People With Prediabetes: Randomized Controlled Trial.

JMIR Mhealth Uhealth. 2020-7-8

[9]
Social Media-Delivered Patient Education to Enhance Self-management and Attitudes of Patients with Type 2 Diabetes During the COVID-19 Pandemic: Randomized Controlled Trial.

J Med Internet Res. 2022-3-23

[10]
Efficacy of a self-management education programme on patients with type 2 diabetes in primary care: A randomised controlled trial.

Prim Care Diabetes. 2019-4

本文引用的文献

[1]
Impact on Knowledge, Competence, and Performance of a Faculty-Led Web-Based Educational Activity for Type 2 Diabetes and Obesity: Questionnaire Study Among Health Care Professionals and Analysis of Anonymized Patient Records.

JMIR Form Res. 2023-9-13

[2]
User Retention and Engagement in the Digital-Based Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (myDESMOND) Program: Descriptive Longitudinal Study.

JMIR Diabetes. 2023-7-21

[3]
Technology-Supported Integrated Care Innovations to Support Diabetes and Mental Health Care: Scoping Review.

JMIR Diabetes. 2023-5-9

[4]
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023.

Diabetes Care. 2023-1-1

[5]
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.

Diabetes Care. 2023-1-1

[6]
6. Glycemic Targets: Standards of Care in Diabetes-2023.

Diabetes Care. 2023-1-1

[7]
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2023.

Diabetes Care. 2023-1-1

[8]
7. Diabetes Technology: Standards of Care in Diabetes-2023.

Diabetes Care. 2023-1-1

[9]
A multi-stakeholder approach is needed to reduce the digital divide and encourage equitable access to telehealth.

J Telemed Telecare. 2023-1

[10]
The Effects of COVID-19 Lockdown on Glycaemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Int J Environ Res Public Health. 2022-1-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索